A Phase 1/2a Study of LON002 (Sublingual Artemether Spray) in Subjects With Advanced Solid Tumours.
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Artemether (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors LondonPharma
- 21 Nov 2014 New trial record